| 注册
首页|期刊导航|药食同源杂志|澳大利亚食药同源健康产品的功能声称及法律法规概况

澳大利亚食药同源健康产品的功能声称及法律法规概况

刘霁娴 周徐陈 李世兰 姜宁 刘毅春 杜巧蓓 王宁 刘新民

药食同源杂志2025,Vol.1Issue(5):1-5,5.
药食同源杂志2025,Vol.1Issue(5):1-5,5.

澳大利亚食药同源健康产品的功能声称及法律法规概况

Overview of functional claims,laws,and regulations of food-medicine homology health products in Australia

刘霁娴 1周徐陈 1李世兰 1姜宁 2刘毅春 3杜巧蓓 1王宁 1刘新民1

作者信息

  • 1. 宁波大学新药技术研究院 天体化学与空间生命—钱学森空间科学协同研究中心,浙江 宁波 315211
  • 2. 中国医学科学院北京协和医学院药用植物研究所,北京 100193
  • 3. 北京康森益友科技有限公司,北京 100095
  • 折叠

摘要

Abstract

Against the backdrop of an intensifying aging population,sustained economic growth,and a rising number of sub-health individuals,food-medicine homology health products have emerged as vital components of daily diets.These products also demonstrate multifaceted health benefits,including nutritional regulation,delaying the progression of chronic diseases,enhancing immunity,and supporting adjuvant therapy.Australia has established a relatively mature functional claim management system,implementing tiered regulatory oversight based on product risk levels.Novel foods are evaluated for ingredient safety and consumption history by Food Standards Australia New Zealand(FSANZ),while listed health products fall under the supervision of the Therapeutic Goods Administration(TGA).Functional claims are permitted only when supported by corresponding scientific evidence.This mechanism provides institutional support and developmental space for product research,development,and functional promotion.It offers valuable insights for advancing the standardized management and functional claim system construction of food-medicine homology health products in China.

关键词

食药同源/健康产品/澳大利亚/功能声称/法律法规

Key words

food-medicine homology/health products/Australia/functional claims/laws and regulations

分类

医药卫生

引用本文复制引用

刘霁娴,周徐陈,李世兰,姜宁,刘毅春,杜巧蓓,王宁,刘新民..澳大利亚食药同源健康产品的功能声称及法律法规概况[J].药食同源杂志,2025,1(5):1-5,5.

基金项目

基于中药国际注册的中巴传统药物国际合作研究项目(S20250268) (S20250268)

宁波市顶尖人才项目(215-432094250). (215-432094250)

药食同源杂志

访问量3
|
下载量0
段落导航相关论文